| Document |
Document Title |
|
WO/2021/037325A1 |
The present invention relates to a method of making a porous sponge-like formulation that can well absorb water, oil and organic solvents separately or combined. Methods of preparing said formulation and its use in medical, pharmaceutica...
|
|
WO/2021/031165A1 |
A ribbon-type tampon, for use in solving the problem that the known tampon absorbs menstrual blood slowly and unevenly. The ribbon-type tampon comprises: an absorber (1) having a plurality of ribbons (11) compressed into a bundle, the pl...
|
|
WO/2021/033078A1 |
Selectable transparency wound dressings and methods intended for use with light switching adhesive systems are provided. The wound dressing may include at least a dressing layer, a drape comprising a flexible film layer for placement pro...
|
|
WO/2021/032704A1 |
The invention relates to a hygiene patch for absorbing sweat from human skin. The hygiene patch has a flexible carrier layer which an adhesive surface that can be fixed to the human skin and an absorbent layer arranged in some portions o...
|
|
WO/2021/015631A9 |
Described herein are multilayer nanofibre compositions with bioactives for wound healing management and related methods. More specifically, a matrix comprising a composition of multifunctional nanofibres layered together including at lea...
|
|
WO/2021/027740A1 |
A multi-lactobacillus composition. The multi-lactobacillus composition is a dominant strain separated and selected from the vagina of a healthy woman in China. The multi-lactobacillus composition comprises at least three of the following...
|
|
WO/2021/030259A1 |
The present disclosure provides a wound dressing in the form of a bandage having a seal strength that is sufficient to allow it to be used in medical applications, and a low trauma, peel-off releasability for the convenience and comfort ...
|
|
WO/2021/028632A1 |
Pharmaceutical composition for topical use (E1) comprising a gelled phase (A1) dispersed in a continuous phase (A2), said pharmaceutical composition (E1) comprising: a gelled phase (A1) comprising at least one anti-inflammatory substance...
|
|
WO/2021/030621A1 |
Disclosed herein are devices and methods for repairing a heart defect. The disclosed devices, comprising a biodegradable gel and a biodegradable mesh scaffold, enhance cellular infiltration, vascularization, and degredation, while reduci...
|
|
WO/2021/028415A1 |
The present invention relates to skin care additive which comprises a diester skin care additive which is the reaction product of a fatty alkoxylated ester and a straight, branched or aromatic polyol or poly acid, where the skin care add...
|
|
WO/2021/023926A1 |
The invention relates to a new composition based on ABA triblock copolymers comprising two thermoplastic styrene terminal blocks A, which are vitreous at the operating temperature, and an elastomer central block B that is a saturated ole...
|
|
WO/2021/024159A1 |
An expandable biodegradable hemostatic matrix comprised of oxidized cellulose, and having a density ranging from about 0.8 to about 1.2 gr/cm3 is disclosed herein. The matrix may be expandable to at least 3 times its original volume with...
|
|
WO/2021/019437A1 |
The present disclosure provides polyacrylate super absorbent polymer (SAP) particles with enhanced absorption rate and method of production thereof.An aspect of the present disclosure provides polyacrylate super absorbent polymer (SAP) p...
|
|
WO/2021/021995A1 |
The presently disclosed subject matter is generally directed to a packaging film constructed from water-dispersible and/or biodegradable compositions. Particularly, the disclosed film comprises a first layer constructed from one or more ...
|
|
WO/2021/022033A1 |
A layered composite for scar treatment and prevention, the layered composite including a backing section; a drug matrix section; and a skin-interfacing section. The drug matrix section may be disposed between the back section and the ski...
|
|
WO/2021/019371A1 |
Dressings, systems, and methods for treating a tissue site are described herein. The dressing has a contact layer having a plurality of holes. The contact layer is configured to be positioned adjacent to the tissue site. The dressing als...
|
|
WO/2021/021851A1 |
A dressing includes an application site covering and an oxygen scavenger provided with or positioned with respect to the application site covering so as to remove oxygen from a volume beneath the application site covering and around an a...
|
|
WO/2021/014422A1 |
The present invention relates to diterpene compounds of general formula (I) capable of contrasting the antibiotic-resistance mediated by the ArnT enzyme, to their use as a medicament, in particular for use as an adjuvant of an antibiotic...
|
|
WO/2021/014297A1 |
A dressing includes a dressing core, a first border coupled to the dressing core and including a silicone adhesive border that surrounds the dressing core, a second border coupled to the first border and including an acrylic adhesive bor...
|
|
WO/2021/015241A1 |
Provided is a mucosal adhesive film that, regardless of the solubility thereof, exhibits a persistent adhesiveness for wet surfaces such as mucous membranes and is capable of a long-term adhesion. The mucosal adhesive film is character...
|
|
WO/2021/014219A2 |
Non-sensitizing pressure sensitive adhesives which are useful in medical applications and other uses where an adhesive is in contact with skin are obtained by energy-curing compositions containing one or more acrylate-functionalized comp...
|
|
WO/2021/009713A1 |
The present disclosure relates generally to wound dressing compositions including a mixture of a collagen and an oxidized cellulose with a coated layer of functional molecules disposed therein. Also disclosed herein are methods of use fo...
|
|
WO/2021/011181A1 |
A negative pressure device includes a drape covering a dressing site on a patient, a sealing element connected with the drape, a flexible gas chamber housing disposed outwardly from the drape with respect to the enclosed chamber, and a r...
|
|
WO/2021/011940A1 |
A method and system for forming a hemostatic hydrocolloid for dispensing into a wound site includes a polymer of oxidized derivatized esterified cellulose in solid form comprising a chain of monomers, wherein, for a first plurality of th...
|
|
WO/2021/010939A1 |
Multi-layered absorbent bodies and methods of manufacture are disclosed. A method of forming an absorbent body may comprise moving a first covering material in a machine direction, moving a reinforcing material in the machine direction a...
|
|
WO/2021/009014A1 |
The present invention relates to a haemostatic powder comprising at least 10 wt.% of particle agglomerates, said particle agglomerates having a diameter in the range of 1-500 μm and comprising: • electrophilic polyoxazoline particles ...
|
|
WO/2021/009013A1 |
The invention relates to a biocompatible, flexible, haemostatic sheet comprising: • a water-resistant cohesive fibrous carrier structure comprising a three-dimensional interconnected interstitial space, said fibrous carrier structure c...
|
|
WO/2021/010940A1 |
Multi-layered absorbent bodies and methods of manufacture are disclosed. An absorbent body may comprise a top, liquid permeable covering material, a bottom covering material, a reinforcing material disposed between the top covering mater...
|
|
WO/2021/009015A1 |
The invention relates to a biocompatible, flexible, haemostatic sheet comprising: • a cohesive fibrous carrier structure comprising a three-dimensional interconnected interstitial space; and • distributed within the interstitial spac...
|
|
WO/2021/006159A1 |
The present invention relates to a wound-covering material having at least a hydrogel, the hydrogel containing fine fibrous cellulose having an ionic substituent. The present invention also relates to a wound-covering material production...
|
|
WO/2021/007584A1 |
Acrylic polymers and pressure sensitive adhesive compositions prepared from (i) from about 1 to about 10 wt% of a carboxy functional monomer component, (ii) from about 50 to about 90 wt% of a low Tg alkyl acrylate monomer component, (iii...
|
|
WO/2021/002729A1 |
The present invention comprises: a silicone gel layer in contact with a wound area of the skin; an adhesive layer for fixing the silicone gel layer to the skin; and an expansion pressing layer interposed between the silicone gel layer an...
|
|
WO/2021/001221A1 |
In a method for measuring characteristics of super-absorbents, the absorption capacity of super-absorbents under pressure is determined, wherein the pressure applied to a sample of the super-absorbent is reduced in stages and the absorpt...
|
|
WO/2021/001281A1 |
The invention relates to a method of depositing a substance onto a substrate (6), comprising: - providing a substrate (6) at a distance from a conducting spraying nozzle (1), said spaying nozzle (1) having an outlet (2); - providing a li...
|
|
WO/2020/257956A1 |
Provided are a bio-cellulose-based skin cleaning product, a preparation method therefor and the use thereof. The bio-cellulose-based skin cleaning product comprises a bio-cellulose wet film and a skin cleanser, wherein the mass ratio of ...
|
|
WO/2020/261188A1 |
The present disclosure relates generally to wound dressing compositions and methods of manufacturing the wound dressing compositions of the present technology. The wound dressing composition includes a mixture of a collagen and/or chitos...
|
|
WO/2020/261190A1 |
The present disclosure provides wound dressing compositions that disrupt biofilm formation in a wound upon application. The wound dressing composition includes a first layer comprising a homogeneous mixture of a collagen, an oxidized reg...
|
|
WO/2020/263894A1 |
Methods, apparatuses, and systems for administering negative pressure therapy to a tissue site are described. The methods, apparatuses and systems can include delivery devices for delivering a flowable tissue dressing material to a tissu...
|
|
WO/2020/261189A1 |
The present disclosure relates generally to wound dressing compositions that include a β-glucan which can stimulate an immunomodulatory effect on cells within a wound, increase the healing rate of a wound, and stimulate the healing of r...
|
|
WO/2020/261609A1 |
This medical patch material comprises a laminate of a support and an adhesive layer, wherein the adhesive layer comprises an adhesive composition containing a copolymer in which a (meth)acrylic acid alkyl ester is the main component and ...
|
|
WO/2020/263900A1 |
Devices for delivering a flowable hydrophilic tissue dressing material for treating a tissue site are described. The devices can also include a flowable hydrophilic tissue dressing material including a reacted polymer, for example, polyv...
|
|
WO/2020/259672A1 |
Disclosed are a fibroin-polypeptide electrospun film for promoting blood coagulation and a preparation method therefor. The electrospun film is prepared by using a silkworm fibroin protein as a carrier and adding a polypeptide GPRPPSEHLQ...
|
|
WO/2020/264042A1 |
A re-closable wound dressing is provided. A base layer is operable to be attached to a skin of a patient. The base layer forms a pre-fabricated aperture through which a wound of the patient is accessible. A cover layer is coupled with th...
|
|
WO/2020/262381A1 |
In this water-soluble hyaluronic acid gel production method, a water-soluble hyaluronic acid gel is provided which can be produced with high productivity and without the need for a step for evaporating a large amount of water from a hyal...
|
|
WO/2020/264132A1 |
The present disclosure relates generally to wound inserts that may include an outer layer and an inner core of biopolymers that may be used in the therapy of tunneling wounds and for facilitating wound healing. Methods of use, methods fo...
|
|
WO/2020/263457A1 |
Dressings for treating a tissue site with negative pressure are disclosed, which may include a dressing having multiple layers and incorporating a material adapted to neutralize proteolytic enzymes. In one example embodiment, a dressing ...
|
|
WO/2020/261187A1 |
The present disclosure relates generally to wound dressing compositions that may be used to disrupt and/or prevent biofilm formation in a wound upon application. The wound dressing can contain bioresorbable polymers. The wound dressing c...
|
|
WO/2020/254676A1 |
The invention relates to a compression bandage comprising a nonwoven-based bandage layer that has been stitched over with elastic textile threads by stitch bonding methods, the textile threads being heat-shrinkable and not elastomeric an...
|
|
WO/2020/256198A1 |
The present invention relates to a microneedle and, more particularly, to a microneedle that can easily be prevented from detaching when inserted into the skin by improving the shape of the microneedle applied to a patch.
|
|
WO/2020/256235A1 |
The present invention relates to a hot-melt adhesive composition and, more specifically, to a hot-melt adhesive composition for bonding pure cotton, which has excellent adhesion to pure cotton fabrics and has an excellent effect of maint...
|
